LT for Unresectable Colorectal Liver Metastasis

Program Status

Recruiting

Phase

Not Applicable

Prior Immunotherapy Allowed

No

CRC-directed Trial

Yes

Tags

MSI-H/ MMRd, MSS/ MMRp
Location Location Status
Korea, Republic of
Seoul National University Hospital
Seoul 03080
Recruiting

Contacts

YoungRok Choi, MD
Contact
82-2072-0069 choiyoungrok@gmail.com

Inclusion Criteria

Inclusion Criteria:

Proven colorectal cancer liver metastases without no other treatment (such as immunotherapy, chemotherapy, surgical resection, and radiofrequency ablation)
Metastasis isolated to liver
Patients selected as a liver transplant recipient at a multidisciplinary meeting
Paitents with a willing, healthy living donor
Willing and able to provide written informed consent

Exclusion Criteria

Exclusion Criteria:

Pregnant women
Known history of human immunodeficiency virus (HIV) infection
Patients with active peptic ulcer within 2 weeks of transplantation
Persistent colorectal cancer after colon resection
Hemodynamically unstable prior to liver transplantation
Progression of LM at any timepoint prior to transplant surgery (assessed in a multidisciplinary meeting)

NCT ID

NCT04874259

Date Trial Added

2021-05-05

Updated Date

2022-09-06